285
ORAL SESSIONS
Final Program
Oral Sessions- Cateogry K
Healthcare-Associated and Surgical Infections and Clinical Epidemiology
Sunday PM
Slide Session
048 Difficulties of Clostridium difficile
Room 254 4:00 p.m. - 6:30 p.m.
Monday AM
Meet-the-Experts
053 Infection Prevention and
Control in Low- and -Middle-
Resource Settings
Esplanade Ballroom 308 7:00 a.m. - 8:15 a.m.
Meet-the-Experts
054 Top Papers in Infection
Prevention and Control, 2011-2012
Room 120 7:00 a.m. - 8:15 a.m.
Symposium
068 Preventing Spread of
M. tuberculosis in Healthcare
Facilities
Room 122 8:30a.m. - 10:30 a.m.
Slide Session
074 Multidrug- Resistant
Organisms and Catheter-Related
Infections
Room 254 8:30 a.m. - 11:00 a.m.
Interactive Symposium
076 Challenges in Infection Control
Room 104 11:15 a.m. - 12:45 p.m.
Monday PM
Interactive Symposium
118 Evidence-Based Infection Preven-
tion and Control: Answering Key
Questions
Room 104 2:00 p.m. - 4:00 p.m.
Slide Session
129 Staphylococcus
aureus: Tough Bug, Tough Treatment
Room 132 2:00 p.m. - 4:00 p.m.
Meet-the-Experts
136 Preventing Line-Associated
Bloodstream Infec- tion: Which Mea-
sures are Essential?
Esplanade Ballroom 308 5:45 p.m. - 7:00 p.m.
Tuesday AM
Meet-the-Experts
138a MDRO Control: What to
Do When Basic Prevention
Measures Don’t Work?
Room 102 7:00 a.m. - 8:15 a.m.
Meet-the-Experts
144 Antimicrobial Resistance and
Antimicrobial Stewardship in Non-
Hospital Settings
Room 120 7:00 a.m. - 8:15 a.m.
Symposium
193 Regional Approaches to
Prevention of Healthcare-Associ-
ated Antimicrobial Resistance
Esplanade Ballroom 300 11:15 a.m. - 12:45 p.m.
Slide Session
199 Bloodstream Infections:
Catheters, Cultures and Counts
Room 121 11:15 a.m. - 12:45 p.m.
Tuesday PM
Symposium
208 Are Prevalence Surveys Still Useful
for Healthcare- Associated Infection
Surveillance?
Esplanade Ballroom 305 2:00 p.m. - 4:00 p.m.
Meet-the-Experts
217 Challenging Issues in Pediatric
Infection Preven- tion and Control
Room 122 5:45 p.m. - 7:00p.m.
Meet-the-Experts
218 Issues in the Diagnosis and
Management of Prosthetic Joint
Infections
Esplanade Ballroom 310 5:45 p.m. - 7:00 p.m.
Wednesday AM
Meet-the-Experts
223 Environmental Cleaning and
Infection Prevention
Room 120 7:00 a.m. - 8:15 a.m.
Symposium
231 A Multifac- eted Approach to
Preventing Surgical Site Infections
Room 121 9:15 a.m. - 11:15 a.m.
Slide Session
239 Antimicrobial Stewardship: Perils
of Prescribing
Esplanade Ballroom 310 9:15 a.m. - 11:45 a.m
286
Oral Sessions
September 9-12 |
Oral Sessions- Category L1
Clinical Trials of Adults with Community-Acquired Infections
Oral Sessions- Category L
Clinical Treatment and Outcome Trials Involving Adult Community-Acquired Infections, Including Obstetrical-Gyneco- logical and Sexually Transmitted Infections
Sunday PM Monday AM
Meet-the-Experts
056 Difficult to Manage Cutaneous
Infections in Adults and Children
Esplanade Ballroom 302 7:00 a.m. - 8:15 a.m.
Symposium
070 New Insights in Diabetic Foot
Infections and Osteomyelitis
Room 121 8:30 a.m. - 10:30 a.m.
Tuesday AM
Slide Session
158 New Insights in Bacterial Meningitis
Esplanade Ballroom 309 8:30 a.m. - 11:00 a.m.
Tuesday PM
Symposium
210 Potluck: The Latest on Foodborne
Infections
Room 132 2:00 p.m. - 4:00 p.m.
Wednesday AM
Symposium
232 What’s New with Pneumococcus?
Esplanade Ballroom 308 9:15 a.m. - 11:15 a.m.
Wednesday PM
Symposium
045 An Update on Perinatal Infections
Room 130 4:00 p.m. - 6:00 p.m.
Sunday PM
Symposium
044 An Update on Novel and
Important Tickborne
Diseases
Room 102 4:00 p.m. - 6:00 p.m.
Monday AM
Meet-the-Experts
055 Challenging Infections in Older
Adults
Esplanade Ballroom 310 7:00 a.m. - 8:15 a.m.
Symposium
069 New Issues in the Management of
MDRXDR TB
Esplanade Ballroom 306 8:30 a.m. - 10:30 a.m.
Symposium
078 50 Years of Fluoroquinolones:
Past, Present and Future
Room 132 11:15 a.m. - 12:45 p.m.
Symposium
079 An Update on Streptococcal
Pharyngitis and Rheumatic Fever
Esplanade Ballroom 302 11:15 a.m. - 12:45 p.m.
Monday PM
Symposium
127 New Issues in the Management
of Multidrug- Resistant MDR
Endocarditis
Esplanade Ballroom 305 2:00 p.m. - 4:00 p.m.
Tuesday AM
Symposium
153 Dangerous Pets and Other Animals
Room 102 8:30 a.m. - 10:30 a.m.
Symposium
154 What Every Clinician Should
Know About Emerging New
Antimicrobials
Esplanade Ballroom 305 8:30 a.m. - 10:30 a.m.
Symposium
194 Emerging and Current Challenges
in Injecting Drug Users
Room 102 11:15 a.m. - 12:45 p.m.
Tuesday PM Wednesday AM
287
ORAL SESSIONS
Final Program
Oral Sessions- Category L2
STD, Urinary Tract and Ob-Gyn Infections
Oral Sessions- Category M
Mycology, Including Resistance and Mechanisms of Action of Antifungals
Sunday PM Monday AM
Symposium
071 An Update on the Treatment and
Prevention of UTIs
Room 102 8:30 a.m. - 10:30 a.m
Monday PM Tuesday AM
Tuesday PM Wednesday AM
Sunday PM
Symposium
046 Mycology 2012: Top Papers
Room 132 4:00 p.m. - 6:00 p.m.
Monday AM
Meet-the-Experts
057 Fungal Infections
Involving the Eye
Room 102 7:00 a.m. - 8:15 a.m.
Symposium
072 Research in Mycology: Hot
Topics
Room 132 8:30 a.m. - 10:30 a.m.
Monday PM
Slide Session
115 Sleuthing in Mycology
Esplanade Ballroom 310 1:30p.m. - 4:00 p.m.
Symposium
128 Fungal Infections in
High-Risk Groups: Current and Future
Strategies for Control
Esplanade Ballroom 302 2:00 p.m. - 4:00 p.m.
Tuesday AM
Interactive Symposium
146 Challenging Cases in Mycology
Room 104 8:30 a.m. - 10:30 a.m.
Slide Session
159 Mycology for the Bedside
Room 122 8:30 a.m. -1:00 a.m.
Tuesday PM
Meet-the-Experts
219 How Can the Mycology Lab Work
for You?
Room 121 5:45p.m. -7:00 p.m.
Wednesday AM
Meet-the-Experts
224 Fungal Infections of
the Central Nervous System
Room 121 7:00 a.m. - 8:15 a.m.
Symposium
233 Controversies in Clinical Mycology
Esplanade Ballroom 300 9:15 a.m. - 11:15 a.m.
288
Oral Sessions
September 9-12 |
Oral Sessions- Category T
Transplantation Infectious Diseases
Oral Sessions- Category V
Virology Non-HIV, Including Resistance, and Non-HIV Viral Opportunistic Infections in HIV-Infected Patients
Oral Sessions- Category P
Global Health, Travel Medicine and Parasitology
Sunday PM Monday AM
Monday PM
Slide Session
116 Infections in Transplant
Recipients
Room 120 1:30 p.m. - 4:00 p.m.
Tuesday AM Tuesday PM
Wednesday AM
Sunday PM
Interactive Symposium
034 Transplantation and the ID
Physician: Management
Strategies for the 21st Century
Room 104 4:00 p.m. - 6:00 p.m.
Monday AM
Meet-the-Experts
059 Persistent Herpes Virus
Viremia: What Does it Mean?
Esplanade Ballroom 300 7:00 a.m. - 8:15 a.m.
Symposium
080 Hot Topics in Viral Hepatitis
Room 130 11:15 a.m. - 12:45 p.m.
Monday PM
Slide Session
117 Respiratory Viruses and Measles
Esplanade Ballroom 309 1:30 p.m. - 4:00 p.m.
Meet-the-Experts
138 New Strategies for Transplantation
of HIV Infected Individuals
Esplanade Ballroom 300 5:45 p.m. - 7:00 p.m.
Tuesday AM
Slide Session
160 Hepatitis and Herpes Viruses
Room 254 8:30 a.m. - 11:00 a.m.
Symposium
195 Influenza: Beyond the
Headlines
Room 130 11:15 a.m. - 12:45 p.m.
Tuesday PM
Symposium
212 Viruses and the Central Nervous
System: Diagnostic, Treatment and
Recent Outbreaks
Room 130 2:00 p.m. - 4:00 p.m.
Wednesday AM
Symposium
235 Recognizing and Managing Anti-
viral Resistance
Room 120 9:15 a.m. - 11:15 a.m.
Sunday PM
Interactive Symposium
033 What’s Hot Where it’s Hot:
Interactive Cases in Tropical Medicine
Room 103 4:00 p.m. - 6:00 p.m.
Monday AM
Meet-the-Experts
058 Top Ten Papers in Travel and
Tropical Medicine
Esplanade Ballroom 306 7:00 a.m. - 8:15 a.m.
Slide Session
075 Parasitology, Global Health and
Travel Medicine
Esplanade Ballroom 309 8:30 a.m. - 11:00 a.m.
Monday PM
Interactive Symposium
119 Clinical Problem Solving:
Interactive Cases in Travel and Tropical
Medicine
Room 103 2:00 p.m. - 4:00 p.m.
Meet-the-Experts
137 Controversies in Pre-Travel Prepara-
tion
Room 122 5:45 p.m. - 7:00 p.m.
Tuesday AM
Symposium
155 Update on Drug Resistance
in Malaria
Esplanade Ballroom 310 8:30 a.m. - 10:30 a.m.
Tuesday PM
Symposium
211 Global Health as an Academic
Discipline
Esplanade Ballroom 310 2:00 p.m. - 4:00 p.m.
Wednesday AM
Symposium
234 Best Practices for Serologic Testing
in Selected Parasitic Diseases
Room 254 9:15 a.m. - 11:15 a.m.
289
POSTER SESSIONS
Final Program
Poster Session- Category A
Antimicrobial Pharmacokinetics, Pharmacodynamics and General Pharmacology
Poster Session- Category B
Therapy in Animal Models, Pathogenesis of Infectious Diseases, Molecular Basis for Pathogenicity, and Host Defenses
Poster Session- Category C1
Antibacterials: Mechanisms of Action, Biochemistry and Genetics of Resistance Antibacterial, not Viral or Fungal
Poster Session- Category C2
Antibacterials: Surveys andor Molecular Epidemiology of Resistance and Resistance Genes, Strains or Serotypes Bacterial, not Viral or Fungal Resistance
Sunday 11:30 a.m. - 1:30 p.m.
Halls A-C
003 PKPD of Carbapenems With or Without Beta-Lactamase
Inhibitors
004 Polymyxins and Aminoglycosides: Optimizing
PKPD and Dosing
Monday 11:15 a.m. - 1:15 p.m.
Halls A-C
082 Glycopeptides and Lipopeptides: What’s New in
PKPD and Safety
083 Improving Pharmaco- dynamics of Beta-Lactams and
Beta-Lactamase Inhibitors
Tuesday 11:15 a.m. - 1:15 p.m.
Halls A-C
161 Clinical Pharmacology of Antiviral and Anti-
Tuberculosis Agents
162 Clinical Pharmacology of Novel Anti-Infective Agents
163 Pharmacokinetics Pharmacodynamics of
New and Old Oxazolidinones
Wednesday 9:15 a.m. - 11:15 a.m.
Halls A-C
240 Antifungals: Improving PKPD and Safety
241 Toxicokinetics and PKPD of New and Old Fluoroquinolones
Sunday 11:30 a.m. - 1:30 p.m.
Halls A-C
005 Immune Response to Microbial Infection
Monday 11:15 a.m. - 1:15 p.m.
Halls A-C
084 Antimicrobial Therapy in Animal Models I
Tuesday 11:15 a.m. - 1:15 p.m.
Halls A-C
164 Antimicrobial Therapy in Animal Models II
165 Microbial Determinants of Virulence
Wednesday 9:15 a.m. - 11:15 a.m.
Sunday 11:30 a.m. - 1:30 p.m.
Halls A-C
006 Carbapenemases and Expanded Spectrum
ơ- Lactamases:
Enterobacteriaceae, S. aeruginosa, A. bumannii
Monday 11:15 a.m. - 1:15 p.m.
Halls A-C
085 Genetics and Resistance 086 Resistance by Efflux
Quinolone Resistance
Tuesday 11:15 a.m. - 1:15 p.m.
Halls A-C
166 Resistance to Staphylococcus
and Other Gram-Positive
Wednesday 9:15 a.m. - 11:15 a.m.
Halls A-C
242 Mechanisms of Resistance to Novel Compounds
Sunday 11:30 a.m. - 1:30 p.m.
Halls A-C
007 AmpCs: Not Going Away 008 Carbapenemases: Will They
Ever End
009 ESBLs: Still Relevant 010 Multi-Center Surveillance
Studies
Monday 11:15 a.m. - 1:15 p.m.
Halls A-C
087 Diverse Resistance Issues in
Enterobacteriaceae 088 Food, Animals and
Environment Reservoirs for Gram-Negative Organisms
089 Pseudomonas aeruginosa: An
Overview of Survelliance Data
Tuesday 11:15 a.m. - 1:15 p.m.
Halls A-C
167 Characterization of Streptococcus pneumoniae in the
Era of Antibiotics and Vaccines
168 Drug-Resistant Mycobacterium tuberculosis
169 MRSA: A Bug with Interna- tional Appeal and Great Sense
Wednesday 9:15 a.m. - 11:15 a.m.
Halls A-C
243 Antimicrobial Resistance of Miscellaneous Bacteria
244 Streptococcus and Enterococus
290
Poster Sessions
September 9-12 |
Poster Session- Category D
Laboratory Tests for Diagnosing Infections; Methods for Antibacterial Susceptibility Testing
Poster Session- Category E
In Vitro Antibacterial Susceptibility Studies and Drug-Combination Interactions
Poster Session- Category F
New Antimicrobial Agents i.e. pre-US IND or prior to the start of any clinical therapeutic studies and New Research Technologies
Sunday 11:30 a.m. - 1:30 p.m.
Halls A-C
011 Clostridium difficile
Diagnosticss 012 Diagnosis of Infections of
Implantable Devices and Biofilms
013 Diagnosis of Respiratory Tract Infections
014 Serologic Methods for Detection of Infectious Diseases
Monday 11:15 a.m. - 1:15 p.m.
Halls A-C
090 MALDI-ToF Mass Spec- trometry and Identification and
Susceptibility Testing
091 Mycobacteria: Diagnostics and Susceptibility Testing
092 Phenotypic Susceptibility Testing Methods
Tuesday 11:15 a.m. - 1:15 p.m.
Halls A-C
170 Detection of Bacteremia and Biomarkers for Sepsis
171 Diagnosis, Characterization and Antimicrobial Susceptibility
Testing: Gram-Positive Cocci
172 Molecular Methods for Pathogen Identification and
Resistance Detection
Wednesday 9:15 a.m. - 11:15 a.m.
Sunday 11:30 a.m. - 1:30 p.m.
Halls A-C
015 In Vitro Activity of Beta- Lactamase Inhibitor
Combinations
016 In Vitro Activity of Fluoroquinolones
Monday 11:15 a.m. - 1:15 p.m.
Halls A-C
093 Cornucopia of In Vitro Activity
094 In Vitro Activity Against Multidrug-Resistant Gram-
Negative Bacteria
095 In Vitro Activity Versus Anaerobes
Tuesday 11:15 a.m. - 1:15 p.m.
Halls A-C
173 In Vitro Activity of Lipoglycopeptides and Related
Compounds
174 In Vitro Activity Versus Staphylococcal
Wednesday 9:15 a.m. - 11:15 a.m.
Halls A-C
245 In Vitro Activity for Mycobacteria
Sunday 11:30 a.m. - 1:30 p.m. Monday 11:15 a.m. - 1:15 p.m.
Halls A-C
096 New Antifungal Agents 097 New Antiviral Agents
098 New Approaches in Mycobac- terial Therapy
099 Targeting the Bacterial Cell Wall: New Beta-Lactams and
Beta-Lactamase Inhibitor Combi- nations
Tuesday 11:15 a.m. - 1:15 p.m.
Halls A-C
175 Antimicrobial Peptides and Peptidomimetics
176 Compounds and Approaches for Combating Gram-Positive
Infections
177 Novel Antimicrobial Approaches and Agents
Wednesday 9:15 a.m. - 11:15 a.m.
Halls A-C
246 New Ways with Old Friends: Repurposing and
Novel Formulations
247 Novel Inhibitors of Bacterial GyrBParE
Topoisomerase Subunits
248 Quinolones and Beyond 249 Targeting Gram-Negative
Pathogens
291
POSTER SESSIONS
Final Program
Poster Session- Category G
Adult and Pediatric Vaccine Studies and Pediatric Infection
Poster Session- Category G3
Studies Relating to Aspects of Pediatric Infections
Poster Session- Category H
HIVAIDS and Other Retroviruses, Including Resistance
Poster Session- Category K
Healthcare-Associated and Surgical Infections and Clinical Epidemiology
Sunday 11:30 a.m. - 1:30 p.m. Monday 11:15 a.m. - 1:15 p.m.
Halls A-C
100 Impact of Expanded Valent: Pneumococcal Vaccines
101 Updates in Vaccines
Tuesday 11:15 a.m. - 1:15 p.m. Wednesday 9:15 a.m. - 11:15 a.m.
Sunday 11:30 a.m. - 1:30 p.m. Monday 11:15 a.m. - 1:15 p.m.
Tuesday 11:15 a.m. - 1:15 p.m.
Halls A-C
178 Pediatrics
Wednesday 9:15 a.m. - 11:15 a.m.
Sunday 11:30 a.m. - 1:30 p.m.
Halls A-C
017 Adherence to HIV Therapy and Care
018 Hepatitis B and C Coinfection in HIV
019 Opportunistic Infections and Co-Morbid Conditions
in HIV-I
Monday 11:15 a.m. - 1:15 p.m.
Halls A-C
102 Antiretroviral Therapy Outcomes Including Select
Populations
103 Safety and Toxicity of Antiretroviral Therapy
Tuesday 11:15 a.m. - 1:15 p.m.
Halls A-C
179 HIV-I Pathogenesis and Predictors of Antiretroviral
Response in Treatment and Prevention
180 HIV-I Resistance, Tropism and Novel Laboratory Methods
Wednesday 9:15 a.m. - 11:15 a.m.
Sunday 11:30 a.m. - 1:30 p.m.
Halls A-C
020 Antibiotic Stewardship and Usage
021 Infection Control and the Environment
022 Prosthetic Joint Infections 023 Surgical Site Infections
024 Vancomyoin-Resistant Enterococci
Monday 11:15 a.m. - 1:15 p.m.
Halls A-C
104 Blood Stream Infections 105
Clostridium difficile Infections 106 Endocarditis
107 Fungal Infections 108 Influenza
Tuesday 11:15 a.m. - 1:15 p.m.
Halls A-C
181 Extended-Spectrum ơ-Lactamase Enterobacteriaceae
182 MRSA Infections 183 Resistant
Acinetobacter Infections
184 Resistant Gram-Negative Infections
185 Use of Vancomycin, Daptomycin andor Linezolid
Wednesday 9:15 a.m. - 11:15 a.m.
Halls A-C
250 Bone Infections 251 Hand Hygiene
252 Vascular Catheter and Device Related Infections
253 Ventilator-Associated Pneumonia
292
Poster Sessions
September 9-12 |
Poster Session- Category L1
Clinical Trials of Adults with Community-Acquired Infections
Poster Session- Category L2
STD, Urinary Tract and Ob-Gyn Infections
Poster Session- Category M
Mycology, Including Resistance and Mechanisms of Action of Antifungals
Sunday 11:30 a.m. - 1:30 p.m.
Halls A-C
025 Antimicrobial Stewardship and OPAT
026 Respiratory Tract Infection
Monday 11:15 a.m. - 1:15 p.m.
Halls A-C
109 An Update on Tuberculosis 110 Zoonotic Infections
Tuesday 11:15 a.m. - 1:15 p.m.
Halls A-C
186 Endocarditis and Other Inva- sive Infections
187 Meningitis and Central Ner- vous System Infections
188 Methicillin-Resistant Staphy-
lococcus aureus: Clinical Aspects 189 Novel Agents and Insights in
Skin and Soft Tissue Infections
Wednesday 9:15 a.m. - 11:15 a.m.
Halls A-C
254 Bone and Joint Infections
Sunday 11:30 a.m. - 1:30 p.m.
Halls A-C
027 Studies in Sexually Transmit- ted Infection
Monday 11:15 a.m. - 1:15 p.m. Tuesday 11:15 a.m. - 1:15 p.m.
Wednesday 9:15 a.m. - 11:15 a.m.
Halls A-C
255 Urinary Tract Infection
Sunday 11:30 a.m. - 1:30 p.m.
Halls A-C
028 Fungal Epidemiology
Monday 11:15 a.m. - 1:15 p.m.
Halls A-C
111 Experimental Mycology
Tuesday 11:15 a.m. - 1:15 p.m.
Halls A-C
190 Clinical Mycology I 191 Clinical Mycology II
Wednesday 9:15 a.m. - 11:15 a.m.
293
POSTER SESSIONS
Final Program
Poster Session- Category T
Transplantation Infectious Diseases
Poster Session- Category V
Virology Non-HIV, Including Resistance, and Non-HIV Viral Opportunistic Infections in HIV-Infected Patients
Poster Session- Category P
Global Health, Travel Medicine and Parasitology
Sunday 11:30 a.m. - 1:30 p.m.
Halls A-C
029 Infections in Transplant Recipients: Viruses and Fungi
Monday 11:15 a.m. - 1:15 p.m.
Halls A-C
113 Infections in Transplant Recipients and Patients with
Malignancies
Tuesday 11:15 a.m. - 1:15 p.m. Wednesday 9:15 a.m. - 11:15 a.m.
Sunday 11:30 a.m. - 1:30 p.m.
Halls A-C
030 Non-HIV Virology
Monday 11:15 a.m. - 1:15 p.m. Tuesday 11:15 a.m. - 1:15 p.m.
Wednesday 9:15 a.m. - 11:15 a.m. Sunday 11:30 a.m. - 1:30 p.m.
Monday 11:15 a.m. - 1:15 p.m.
Halls A-C
112 Global Health, Parasitology and Travel Medicine
Tuesday 11:15 a.m. - 1:15 p.m. Wednesday 9:15 a.m. - 11:15 a.m.
294
September 9-12 |
Not es
Notes
295
LATE-BREAKER SCIENTIFIC SESSIONS
Final Program 003 A
Poster Session
PKPD of Carbapenems With or Without Beta-Lacta- mase Inhibitors
Sunday, 11:30 AM - 1:30 PM . . . . . . . . . . . . . . . . . . . . . Halls A-C
Presentation: A-022a
Efficacy of Humanized Carbapenem Exposures against New Delhi Metallo-Beta-Lactamase NDM-1 Producing
Enterobacte- riaceae in a Murine Infection Model
D. E. Wiskirchen
